Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

JC&C Interim Management Statement

9 Nov 2023 09:31

RNS Number : 9422S
Jardine Matheson Hldgs Ltd
09 November 2023
 

 

To: Business Editor 9th November 2023 For immediate releaseJardine Cycle & Carriage Limited Interim Management Statement The following announcement was issued today by the Company's 77.7%-owned subsidiary, Jardine Cycle & Carriage Limited.For further information, please contact:Jardine Matheson LimitedJoey Ho (65) 9765 0717Brunswick Group LimitedBen Fry (65) 9017 98869th November 2023JARDINE CYCLE & CARRIAGE LIMITEDINTERIM MANAGEMENT STATEMENT Jardine Cycle & Carriage ("JC&C" or "the Group") today issues its Interim Management Statement for the third quarter of 2023.The Group performed well in the first nine months of 2023, mainly due to higher contributions from Astra and Direct Motor Interests, reflecting the resilience of the portfolio. While growth is expected to moderate in the remainder of the year due to ongoing economic challenges, geopolitical uncertainties and reduced coal prices, the Group expects full-year results to be satisfactory.Astra reported a 17% increase in underlying earnings, excluding fair value adjustments from its equity investments, with improvements mainly from its automotive and financial services divisions. Astra's automotive division achieved higher car and motorcycle sales and increased market share. Astra's financial services division also benefitted from the growth in automotive sales and saw higher lending volumes as well as lower loss provisions. Profit from the group's heavy equipment and mining division was flat, reflecting lower coal selling prices despite improved performances from heavy equipment and mining contracting operations. The agribusiness division was impacted by lower crude palm oil prices.THACO's automotive operations were substantially impacted by greater competitive pressure and the weak automotive market due to the slowdown of Vietnam's economy. Losses from its agricultural operations were, however, lower than in 2022.Direct Motor Interests delivered an improved performance. Tunas Ridean in Indonesia recorded higher operating volumes across its automotive, financial services and leasing businesses. Cycle & Carriage Bintang in Malaysia saw an increase in profitability, while Cycle & Carriage in Singapore recorded lower new and used car sales amidst a tightened COE cycle, but this was partly offset by improved aftersales throughput volumes.Results from Other Strategic Interests were lower, as Siam City Cement continued to be adversely impacted by lower sales volumes and high energy costs.JC&C recorded lower foreign exchange losses on its foreign currency loans compared to the equivalent period last year. CORPORATE PROFILE Jardine Cycle & Carriage ("JC&C" or "the Group") is the investment holding company of the Jardine Matheson Group ("Jardines") in Southeast Asia. Listed on the Mainboard of the Singapore Exchange and a constituent of the Straits Times Index, the Group is 77%-owned by Jardines.By investing in the region's market leaders, we aim to deliver sustainable growth to create evermore opportunities for the people and communities of Southeast Asia. The JC&C regional portfolio includes Astra, THACO, Direct Motor Interests and Other Strategic Interests. Together with our subsidiaries and associates, JC&C provides over 240,000 jobs across the region.For more information on JC&C and our businesses, visit www.jcclgroup.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFSUSUUEDSEEF
Date   Source Headline
29th May 202610:53 amRNSTotal Voting Rights
29th May 202610:47 amRNSDirector/PDMR Shareholding
28th May 202611:31 amRNSTransaction in Own Shares
27th May 202610:27 amRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSAcquisition of I-MED Radiology Network
22nd May 202610:23 amRNSInterim Management Statement
19th May 202612:22 pmRNSINTERIM MANAGEMENT STATEMENT
18th May 202612:57 pmRNSNotification of Issuance of Equity Securities
18th May 202612:30 pmRNSDirector/PDMR Shareholding
7th May 20261:01 pmRNSAdditional Listing
7th May 202612:49 pmRNSDirector/PDMR Shareholding
7th May 202612:44 pmRNSResult of AGM
5th May 202610:54 amRNSTransaction in Own Shares
5th May 202610:19 amRNSTransaction in Own Shares
30th Apr 202611:51 amRNSTotal Voting Rights
30th Apr 202611:50 amRNSTransaction in Own Shares
30th Apr 202610:47 amRNSJC&C Interim Management Statement
29th Apr 202612:28 pmRNSPT Astra 2026 First Quarter Financial Statements
29th Apr 202611:59 amRNSTransaction in Own Shares
29th Apr 202610:48 amRNSDividend
28th Apr 202611:35 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 202611:26 amRNSDividend
22nd Apr 202611:12 amRNSTransaction in Own Shares
21st Apr 202610:57 amRNSTransaction in Own Shares
20th Apr 202611:01 amRNSTransaction in Own Shares
14th Apr 202611:31 amRNSTransaction in Own Shares
13th Apr 202611:27 amRNSTransaction in Own Shares
10th Apr 202611:23 amRNSTransaction in Own Shares
8th Apr 202611:53 amRNSTransaction in Own Shares
8th Apr 202610:25 amRNSAnnual Financial Report
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20268:02 amRNSTransaction in Own Shares
1st Apr 202611:17 amRNSTransaction in Own Shares
1st Apr 202610:34 amRNSCirc re. Scrip Dividend Scheme
1st Apr 202610:21 amRNSDirector/PDMR Shareholding
31st Mar 202611:59 amRNSDirector/PDMR Shareholding
31st Mar 202611:53 amRNSTotal Voting Rights
31st Mar 202611:46 amRNSTransaction in Own Shares
30th Mar 202611:08 amRNSTransaction in Own Shares
27th Mar 20269:43 amRNSDirector/PDMR Shareholding
25th Mar 202611:05 amRNSDirector/PDMR Shareholding
25th Mar 202610:31 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 202611:07 amRNSTransaction in Own Shares
20th Mar 20269:26 amRNSDirector/PDMR Shareholding
17th Mar 20269:55 amRNSDirector/PDMR Shareholding
16th Mar 20269:57 amRNSDirector/PDMR Shareholding
16th Mar 20269:57 amRNSDirector/PDMR Shareholding
13th Mar 20269:42 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.